Washington: Tech billionaire Elon Musk has publicly supported former US President Donald Trump’s latest executive order that prohibits federal funding for gender transition procedures for minors. The order, signed on Tuesday, aims to halt gender-affirming treatments such as hormone therapy and surgeries for individuals under the age of 19, sparking intense debate nationwide.
Musk, known for his outspoken social media presence, took to X (formerly Twitter) to express his views. “Children cannot consent. That is why there are laws protecting minors. Those who perpetrated this evil should be in prison for life,” he wrote, aligning with Trump’s stance against medical procedures for transgender youth.
Trump’s Executive Order and Its Implications
Trump’s new executive order directs government agencies to block federal funding for any institution providing gender-affirming medical treatments to minors. In his announcement, the former president declared, “Our nation will no longer fund, sponsor, promote, assist, or support so-called ‘gender-affirming care,’ which has already ruined far too many precious lives.” The move specifically targets federal programs such as Medicaid, Medicare, and the US Department of Defense’s healthcare plans.
A Heated National Debate
The decision has reignited the ongoing debate over gender-affirming care for minors in the United States. Republican-led states have already enacted strict bans on gender transition procedures for minors, and this federal action further strengthens the conservative push against such treatments.
Supporters of the ban, including Musk and Trump, argue that minors lack the maturity to make irreversible medical decisions and that such treatments could have lasting physical and psychological consequences. However, opponents, including medical professionals and LGBTQ advocacy groups, argue that gender-affirming care is vital for transgender youth, often leading to improved mental health and reduced suicide risks.
With this latest development, the battle over transgender rights and medical autonomy in the US continues to be a deeply polarizing issue, likely to remain a key topic in upcoming political debates and court challenges.
